ADIL- Adial Pharmaceuticals, Inc.
Over the past 90 days, insiders at Adial Pharmaceuticals, Inc. (ADIL) have been net buyers, picking up 11,753 shares worth roughly $33K on balance.
ADIL sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 385.1K | $1.66M | - |
Activity
Buys and sells only
Transactions
10 filings
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 10, 2026 | Coastlands Capital LP | 10% Owner | Buy | 11,753 | $2.78 | $32,637.87 | +1.6% | - | - | |
| Sep 29, 2023 | Schuyler Kevin | Director | Buy | 700 | $2.74 | $1,918.00 | New | -36.3% | -63.7% | |
| Dec 30, 2021 | Newman James W. Jr. | Director | Buy | 25,000 | $2.69 | $67,300.00 | +31.3% | -25.1% | -91.9% | |
| Nov 30, 2021 | Stilley William B. III | Chief Executive Officer | Buy | 20,600 | $2.67 | $55,070.62 | +1.1% | -25.9% | -90.3% | |
| Nov 26, 2021 | Newman James W. Jr. | Director | Buy | 10,000 | $2.85 | $28,500.00 | +40.9% | -23.5% | -90.2% | |
| Oct 4, 2021 | Johnson Bankole A. | Chief Medical Officer | Sell | 200,000 | $0.00 | - | -57.4% | -26.6% | -90.1% | |
| Apr 6, 2021 | Johnson Bankole A. | Chief Medical Officer | Sell | 150,000 | $2.50 | $375,000.00 | -21.5% | +13.1% | -26.3% | |
| Aug 20, 2020 | Johnson Bankole A. | Chief Medical Officer | Sell | 350,000 | $1.21 | $423,500.00 | -99.7% | - | - | |
| Mar 27, 2020 | Newman James W. Jr. | Director | Buy | 19,644 | $1.36 | $26,769.40 | +84.4% | - | - | |
| Mar 26, 2020 | Stilley William B. III | Chief Executive Officer | Buy | 25,000 | $1.30 | $32,551.68 | +1.8% | - | - |
Page 1Next →